ASPIRUS MEDICAL GROUP INC
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$40,661,636
Property, Plant, & Equipment (net)
35%
Receivables (Non-Related)
29%
Other Assets
25%
Investments
5%
Inventories
4%
Prepaid Expenses
<1%
Cash & Equivalents
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$46,947,604
Payables & Accruals
77%
Other Liabilities
14%
Tax-Exempt Bond Liabilities
9%
Grants Payable
0%
Deferred Revenue
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$136,389
$156,148
+14%
Receivables (Non-Related)
$12,952,769
$11,909,626
-8%
Related-Party Receivables
-
-
-
Inventories
$1,380,134
$1,442,157
+4%
Prepaid Expenses
$275,372
$293,896
+7%
Investments
$3,343,431
$2,121,616
-37%
Property, Plant, & Equipment (net)
$15,985,081
$14,378,360
-10%
Other Assets
$78,098,382
$10,359,833
-87%
Total Assets
$112,171,558
$40,661,636
-64%
Liabilities
2023
2024
Change
Payables & Accruals
$36,498,978
$36,064,746
-1%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
$4,600,000
$4,134,297
-10%
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$73,693,377
$6,748,561
-91%
Total Liabilities
$114,792,355
$46,947,604
-59%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
-$2,620,797
-$6,285,968
-140%
Net assets
2023
2024
Change
Net assets
-$2,620,797
-$6,285,968
-140%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)